Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name CYC065
Trade Name
Synonyms Fadraciclib|CYC-065|CYC 065
Drug Descriptions

CYC065 (Fadraciclib) inhibits CDK2, CDK5, and CDK9, potentially resulting in decreased tumor cell growth (PMID: 28376145, PMID: 27351214, PMID: 32645016).

DrugClasses CDK2 Inhibitor 23 CDK5 Inhibitor 8 CDK9 Inhibitor 19
CAS Registry Number 1070790-89-4
NCIT ID C123902


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
ABT-737 + CYC065 ABT-737 CYC065 0 0
BMS986158 + CYC065 BMS986158 CYC065 0 1
CYC065 CYC065 6 3
CYC065 + Navitoclax CYC065 Navitoclax 0 0
CYC065 + Venetoclax CYC065 Venetoclax 0 1

Additional content available in CKB BOOST